Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 160.59
kr 14453.51kr 160.59
kr 1926.14
60 tablet
Free AirMail shipping Hot
kr 171.30
kr 10277.90kr 171.30
kr 641.87
30 tablet
Free AirMail shipping Hot
kr 182.00
kr 5459.88kr 182.00
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 192.71
kr 17344.32kr 192.71
kr 962.53
60 tablet
Free AirMail shipping Hot
kr 198.07
kr 11883.90kr 198.07
kr 320.67
30 tablet
Free AirMail shipping Hot
kr 203.41
kr 6102.28kr 203.41
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 230.19
kr 20716.93kr 230.19
kr 962.53
60 tablet
Free AirMail shipping Hot
kr 235.54
kr 14132.31kr 235.54
kr 320.67
30 tablet
Free AirMail shipping Hot
kr 240.88
kr 7226.49kr 240.88
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.